RxDoctor Payments Data

Caitlin Booze

Family · Lebanon, NHNPI 1922531367

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 92.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $3,336, more than ten times the $14 reported in 2021. Among family clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,803in general payments, 2019–2025

Across 59 payments — averaging $115.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$6K
  • Inari Medical, Inc.$158
  • Medtronic$97
  • Biotronik Inc.$97
  • Impulse Dynamics (USA) Inc.$91
  • Biosense Webster, Inc.$54
  • plus $21 from 1 others

What the payments were for

  • Consulting fees$3,88057%
  • Travel & lodging$1,14717%
  • Food & beverage$1,77626%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,803 in reported general payments places this provider in the 95th percentile of 713 family providers in New Hampshire.

See all family providers in New Hampshire

Medicare billing

Part B allowed, 2024
$16,841
Medicare patients
220
Services billed
324

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban195$196,111
XareltoRivaroxaban44$35,643
MultaqDronedarone Hcl42$35,074
Flecainide Acetate41$2,916
Metoprolol Succinate136$1,739
Amiodarone Hcl77$1,178
SotalolSotalol Hcl55$989
Torsemide19$652
Nadolol15$623
Potassium Chloride19$516
Pantoprazole Sodium32$492
Diltiazem 24hr Er (Cd)Diltiazem Hcl20$305
Lisinopril41$287
Losartan Potassium30$237
Atorvastatin Calcium46$224

Paid to pharmacies, not to this prescriber.

Other family in Lebanon

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →